Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)

SHE:002370 Revenue

Zhejiang Yatai Pharmaceutical had revenue of 97.95M CNY in the quarter ending June 30, 2026, with 11.91% growth. This brings the company's total for the last twelve months to 328.58M, down -2.01% year-over-year. In the year 2025, Zhejiang Yatai Pharmaceutical had annual revenue of 323.14M, down -20.25%. That makes Zhejiang Yatai Pharmaceutical the 28,083rd largest company in the world by revenue and 4,818th in China.

• Revenue (ttm): 328.58M
• Revenue Growth: -2.01%
• P/S Ratio: 10.85
• Revenue / Employee: 643.02K
• Employees: 511
• Market Cap: 3.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Antibiotic Products 172.60M 53.4%
• Non-Antibiotic 148.79M 46.0%
• Unallocated Other Operating Income 1.75M 0.5%

By Geography

Chart

• China 323.12M 100.0%
• Overseas 12.94K 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:002370 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	323.14M	-82.04M	-20.25%
Dec 31, 2024	405.17M	-15.47M	-3.68%
Dec 31, 2023	420.64M	47.20M	12.64%
Jan 1, 2023	373.44M	58.31M	18.50%
Jan 1, 2022	315.13M	-199.75M	-38.80%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error